The gene expression of SOX2 is highly expressed in NSCLC subtypes, and the inhibition of Sox2 downregulates Wnt1/2 and c-myc gene expression, induces cell apoptosis, and reduces metastatic potential in lung cancer [28,29]. The gene discussed is MYC; the disease is lung carcinoma.